SCHEMBL9371306

SCHEMBL9371306

CC1(C)C=Nc2ccc(C3=NNC(=O)CC3)cc21

nearest known ligand 0.60

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 14/20 0.60
PDE3A Q14432 14/20 0.60
PDE4B Q07343 7/20 0.60
PDE4A P27815 6/20 0.60
PDE4C Q08493 6/20 0.60
PDE4D Q08499 6/20 0.60
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 1/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9372484 0.78 PDE3B (0.62) PDE3BPDE3APDE4BPDE4APDE4C
Hydrochloric Acid SCHEMBL10333797 0.77 PDE3B (0.60) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL9367299 0.76 PDE3B (0.56) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL9367237 0.75 PDE3B (0.58) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL7636343 0.75 PDE3B (0.64) PDE3BPDE3APDE4BPDE4APDE4C
Indolidan SCHEMBL29605502 0.75 PDE3B (1.00) PDE3BPDE3APDE4BPDE4APDE4C
Indolidan SCHEMBL124043 0.75 PDE3B (1.00) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL9367616 0.74 PDE3B (0.57) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL9371436 0.74 PDE3B (0.57) PDE3BPDE3APDE4BPDE4APDE4C
SCHEMBL7483850 0.74 PDE3B (0.70) PDE3BPDE3APDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0280224-B1 Substituted 3H-indoles, process for their preparation and medicines containing them BOEHRINGER MANNHEIM GMBH (DE) 1994-06-01 EP disclosed
US-4925845-A HYPOTENSIVE AGENTS BOEHRINGER MANNHEIM GMBH (DE) 1990-05-15 US disclosed
EP-0280224-A2 Substituted 3H-indoles, process for their preparation and medicines containing them Roche Diagnostics GmbH (DE) 1988-08-31 EP disclosed